Arterial steroid injection therapy can inhibit the progression of severe acute hepatic failure toward fulminant liver failure

doi:10.3748/wjg.v12.i41.6678

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 41

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3129)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

281

HTML

2401

Figures (1-1)

235

Tables (1-3)

212

Sum=3129

Nov 7, 2006 (publication date) through Jan 9, 2025

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Nov 7, 2006; 12(41): 6678-6682
Published online Nov 7, 2006. doi: 10.3748/wjg.v12.i41.6678

Open in New Tab Full Size Figure Download Figure

Figure 1 Improvement of serum ALT concentrations (open circle) and PT-INR (closed circle) in the conservatively cured survivors after TASIT (mean ± SD).

Citation: Kotoh K, Enjoji M, Nakamuta M, Yoshimoto T, Kohjima M, Morizono S, Yamashita S, Horikawa Y, Yoshimitsu K, Tajima T, Asayama Y, Ishigami K, Hirakawa M. Arterial steroid injection therapy can inhibit the progression of severe acute hepatic failure toward fulminant liver failure. World J Gastroenterol 2006; 12(41): 6678-6682
URL: https://www.wjgnet.com/1007-9327/full/v12/i41/6678.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i41.6678